Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Jan-22 | Jan-23 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 325 | 508 | 655 | 670 | 753 | 934 | 1,039 | 1,298 | 1,176 | 1,169 | | 1,170 |
% Growth | NA | 56.5% | 28.9% | 2.4% | 12.4% | 24.0% | 11.2% | 25.0% | -9.4% | -0.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | (163) | (281) | (383) | (396) | (449) | (544) | (604) | (858) | (762) | (850) | | (857) |
Gross Profit | 161 | 227 | 272 | 274 | 304 | 390 | 434 | 440 | 414 | 319 | | 313 |
% Revenue | 49.7% | 44.7% | 41.5% | 40.9% | 40.4% | 41.8% | 41.8% | 33.9% | 35.2% | 27.3% | | 26.7% |
| | | | | | | | | | | | |
Research and Development | (30) | (59) | (85) | (85) | (94) | (114) | (117) | (119) | (115) | (118) | | (92) |
Selling and Marketing | (31) | (59) | (65) | (67) | (60) | (85) | (79) | (74) | (64) | (81) | | (70) |
General and Admin | (82) | (118) | (145) | (70) | (93) | (119) | (143) | (177) | (185) | (199) | | (201) |
Other Inc / (Exp) | 29 | 56 | 82 | 7 | 4 | 5 | (2) | (3) | 3 | (28) | | (28) |
Total Operating Exp | (114) | (180) | (214) | (216) | (244) | (313) | (341) | (371) | (361) | (426) | | (391) |
| | | | | | | | | | | | |
Operating Income | 47 | 47 | 58 | 58 | 60 | 77 | 93 | 69 | 52 | (107) | | (79) |
% Revenue | 14.5% | 9.3% | 8.9% | 8.7% | 8.0% | 8.3% | 9.0% | 5.3% | 4.5% | -9.1% | | -6.7% |
| | | | | | | | | | | | |
Interest Expense | (8) | (8) | (13) | (17) | (20) | (34) | (35) | (36) | (39) | (47) | | (58) |
Pre-tax Income | 39 | 39 | 45 | 42 | 40 | 43 | 58 | 33 | 14 | (154) | | (137) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (5) | (4) | (3) | (1) | 2 | 3 | 4 | 5 | 8 | 21 | | 6 |
Net Income to Company | 34 | 35 | 43 | 40 | 42 | 46 | 62 | 38 | 22 | (133) | | (130) |
% Margin | 10.6% | 6.9% | 6.5% | 6.0% | 5.6% | 4.9% | 6.0% | 2.9% | 1.9% | -11.4% | | -11.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 3 | (2) | (0) | (0) | 10 | | 10 |
Net Income to Stockholders | 34 | 35 | 43 | 40 | 43 | 50 | 61 | 37 | 22 | (123) | | (121) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 34 | 35 | 43 | 40 | 43 | 50 | 61 | 37 | 22 | (123) | | (121) |
% Margin | 10.6% | 6.9% | 6.5% | 6.0% | 5.7% | 5.3% | 5.8% | 2.9% | 1.9% | -10.5% | | -10.3% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.12 | 0.11 | 0.13 | 0.10 | 0.09 | 0.11 | 0.13 | 0.08 | 0.05 | (0.27) | | (0.27) |
Diluted EPS (Continuing Ops) | 0.12 | 0.11 | 0.13 | 0.10 | 0.09 | 0.11 | 0.13 | 0.08 | 0.05 | (0.27) | | (0.27) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 297.53 | 330.02 | 334.95 | 392.18 | 456.33 | 464.00 | 465.62 | 467.07 | 437.66 | 455.52 | | 466.67 |
WA Diluted Shares Out. | 297.53 | 330.02 | 334.95 | 392.18 | 456.33 | 464.00 | 465.62 | 467.07 | 437.66 | 455.52 | | 466.67 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 39 | 39 | 45 | 42 | 40 | 43 | 58 | 33 | 14 | (154) | | (137) |
Addback: Net Interest Expense | 8 | 8 | 13 | 17 | 20 | 34 | 35 | 36 | 39 | 47 | | 58 |
Addback: Other Non Operating Expenses, Total | 1 | 2 | 3 | 1 | 4 | 1 | 8 | 10 | 5 | 7 | | 10 |
Addback: Depreciation & Amortization | 1 | 2 | 2 | 2 | 4 | 7 | 14 | 24 | 27 | 9 | | (4) |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 34 | | 34 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 2 | 1 | 0 | 0 | 1 | (0) | (0) | (0) | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | (0) | | (0) |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | | (0) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (1) | (0) | (1) | 0 | (2) | (2) | (3) | (5) | (5) | (7) | | (7) |
Adjusted EBITDA | 49 | 51 | 63 | 63 | 66 | 82 | 114 | 98 | 82 | (64) | | (47) |
% Margin | 15.0% | 10.0% | 9.6% | 9.3% | 8.8% | 8.8% | 11.0% | 7.6% | 6.9% | -5.4% | | -4.0% |
| | | | | | | | | | | | |
Adjusted EBIT | 47 | 49 | 61 | 61 | 63 | 76 | 99 | 74 | 54 | (73) | | (42) |
% Margin | 14.6% | 9.6% | 9.3% | 9.0% | 8.3% | 8.1% | 9.6% | 5.7% | 4.6% | -6.2% | | -3.6% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 34 | 35 | 43 | 40 | 42 | 46 | 62 | 38 | 22 | (133) | | (130) |
Addback: Unusual Items | (1) | (0) | 0 | 1 | (2) | (2) | (2) | (5) | (3) | 27 | | 27 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | (0) | (0) | 0 | 1 | 1 | 1 | 1 | (7) | | (7) |
Adjusted Net Income | 34 | 35 | 43 | 41 | 41 | 45 | 61 | 34 | 20 | (114) | | (111) |
% Margin | 10.4% | 6.9% | 6.6% | 6.1% | 5.4% | 4.8% | 5.8% | 2.6% | 1.7% | -9.7% | | -9.5% |